Palvella Therapeutics Overview
Palvella Therapeutics Discounted Cash Flow
DCF Analysis for PVLA.
Get informed when a big investor buys or sells
+ FollowFair Value
$5.10
Current Fair Value
$5.10
↓ 95.3% Downside
Overvalued by 95.3% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison